Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rigel Pharmaceuticals, Inc. - Common Stock
(NQ:
RIGL
)
38.70
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rigel Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For August 2, 2022
↗
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Earnings Outlook For Rigel Pharmaceuticals
↗
August 01, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
↗
June 28, 2022
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 27, 2022
Gainers
Via
Benzinga
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
↗
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
↗
June 23, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
Via
Benzinga
3 Stocks Under $1 Insiders Are Buying
↗
June 14, 2022
The Nasdaq Composite dropped by more than 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
↗
June 09, 2022
Upgrades
Via
Benzinga
63 Biggest Movers From Yesterday
↗
June 17, 2022
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
June 09, 2022
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
↗
June 09, 2022
Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.
Via
Benzinga
83 Biggest Movers From Yesterday
↗
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; HeartCore Enterprises Shares Spike Higher
↗
June 08, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dipping over 300 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 08, 2022
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; Rigel Pharmaceuticals Shares Slide
↗
June 08, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite adding around 50 points on Wednesday.
Via
Benzinga
Why Rigel Pharmaceuticals Shares Are Falling Today
↗
June 08, 2022
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares are trading lower after the company announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
↗
June 08, 2022
Upgrades
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
↗
June 08, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.
Via
Benzinga
Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial
↗
June 08, 2022
Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA).
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
June 07, 2022
Good morning! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
↗
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
↗
May 24, 2022
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 03, 2022
Gainers
Via
Benzinga
Recap: Rigel Pharmaceuticals Q1 Earnings
↗
May 03, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
↗
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Preview: Rigel Pharmaceuticals's Earnings
↗
May 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
Earnings Scheduled For May 3, 2022
↗
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022
↗
March 23, 2022
Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and...
Via
Benzinga
Looking Into Rigel Pharmaceuticals's Return On Capital Employed
↗
March 07, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) brought in sales totaling $20.41 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.06%, resulting in...
Via
Benzinga
68 Biggest Movers From Yesterday
↗
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
